- Home
- BNTX vs DD Comparison
BNTX vs DD Comparison
Compare BNTX & DD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | DD |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 20.2B |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BNTX | DD |
|---|---|---|
| Price | $93.02 | $146.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $133.46 | $56.67 |
| AVG Volume (30 Days) | 890.8K | ★ 1.1M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.79% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.22 |
| Revenue | N/A | ★ $20,397,000,000.00 |
| Revenue This Year | N/A | $6.72 |
| Revenue Next Year | $3.37 | $3.83 |
| P/E Ratio | ★ N/A | $64.91 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $79.81 | $33.34 |
| 52 Week High | $124.00 | $149.42 |
Technical Indicators
Market Signals| Indicator | BNTX | DD |
|---|---|---|
| Relative Strength Index (RSI) | 53.05 | 70.25 |
| Support Level | $89.04 | $131.09 |
| Resistance Level | $94.18 | $149.42 |
| Average True Range (ATR) | 2.53 | 4.41 |
| MACD | 0.09 | -1.57 |
| Stochastic Oscillator | 76.81 | 83.10 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About DD DuPont de Nemours Inc.
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the healthcare, water, construction, automotive, aerospace, and printing and packaging industries. Healthcare and water will generate the majority of profits.